Allurion Technologies Inc - SIC # 7372 - PREPACKAGED SOFTWARE

Ticker Exchange SIC # Website Latest Ticker
ALUR New York 7372 https://www.allurion.com/en

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Allurion Technologies Inc

Allurion Receives Continued Listing Standards Notice from NYSE - Sep 5th, 2024 9:30 pm
Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity - Sep 5th, 2024 12:00 pm
Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors - Sep 3rd, 2024 12:00 pm
Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program - Aug 28th, 2024 12:28 pm
Allurion Announces the Appointment of Adrian Wild as Senior Vice President, International Commercial - Aug 20th, 2024 12:00 pm
Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update - Aug 13th, 2024 12:00 pm
Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024 - Jul 16th, 2024 8:05 pm
Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement - Jun 28th, 2024 1:06 pm
Allurion Announces Launch of Offering of Common Stock and Warrants - Jun 26th, 2024 12:36 pm
Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss - Jun 20th, 2024 12:00 pm
Sidoti Events, LLC's Virtual June Small-Cap Conference - Jun 11th, 2024 2:50 pm
Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Jun 11th, 2024 1:35 pm
Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery - Jun 11th, 2024 12:00 pm
Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer - Jun 5th, 2024 12:00 pm
Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s - May 30th, 2024 12:00 pm
Allurion to Participate in Two Upcoming Investor Conferences in June 2024 - May 29th, 2024 8:05 pm
Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss - May 15th, 2024 12:00 pm
Allurion Reports First Quarter 2024 Financial Results and Provides Business Update - May 14th, 2024 12:00 pm
Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey - May 2nd, 2024 12:00 pm
Allurion Announces Preliminary First Quarter 2024 Results - Apr 30th, 2024 12:30 pm